Lifevantage (NASDAQ: LFVN) reported Q3 EPS of $0.08, $0.07 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $53.7 million versus the consensus estimate of $52.09 million.

GUIDANCE:

Lifevantage sees FY2023 EPS of $0.20-$0.26. Lifevantage sees FY2023 revenue of $209-212 million, versus the consensus of $206.4 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.